Metropolis Healthcare Ltd.

NSE: METROPOLIS BSE: 542650 SECTOR: Hospital & Healthcare Services  69k   518   47

1203.65
+7.20 (0.60%)
NSE: 29 Mar 4:00 PM

Price Summary

Today's High

₹ 1210

Today's Low

₹ 1181.05

52 Week High

₹ 2565.4

52 Week Low

₹ 1182.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

6163.97 Cr.

Enterprise Value

6312.55 Cr.

No. of Shares

5.12 Cr.

P/E

38.02

P/B

6.59

Face Value

₹ 2

Div. Yield

0.66 %

Book Value (TTM)

₹  182.56

CASH

109.96 Cr.

DEBT

258.55 Cr.

Promoter Holding

49.76 %

EPS (TTM)

₹  31.66

Sales Growth

16.2%

ROE

26.18 %

ROCE

32.73%

Profit Growth

5.25 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 22 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.2%
3 Year24.33%
5 Year25.7%

Profit Growth

1 Year5.25%
3 Year23.74%
5 Year19.38%

ROE%

1 Year26.18%
3 Year27.26%
5 Year27.68%

ROCE %

1 Year32.73%
3 Year35.84%
5 Year37.92%

Debt/Equity

0.3183

Price to Cash Flow

25.99

Interest Cover Ratio

11.8386578559481

CFO/PAT (5 Yr. Avg.)

1.11145633332788

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 49.76 1.18
Sep 2022 49.76 1.18
Jun 2022 49.79 1.18
Mar 2022 49.79 1.18
Dec 2021 49.5 2.67
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 23.7432832048981% for the Past 3 years.
  • The company has shown a good revenue growth of 24.3339746966269% for the Past 3 years.
  • Company has been maintaining healthy ROE of 27.2568669342531% over the past 3 years.
  • Company has been maintaining healthy ROCE of 35.8390234030701% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 11.8386578559481.
  • The Company has been maintaining an effective average operating margins of 27.4699626721052% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -73.9068914326012 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.11145633332788.

 Limitations

  • The company is trading at a high PE of 38.02.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 271.85 217.99 257.02 280.06 264.56
Total Expenditure 204.54 172.28 195.99 205 199.05
Operating Profit 67.31 45.72 61.03 75.06 65.5
Other Income 2.43 44.49 2.42 2.93 6.79
Interest 4.91 5.37 7.5 6.92 5.97
Depreciation 15.99 11.95 20.37 20.4 21.95
Exceptional Items 0 0 0 0 0
Profit Before Tax 48.83 72.88 35.58 50.67 44.38
Tax 12.44 9.77 7.2 12.86 11.55
Profit After Tax 36.39 63.11 28.38 37.82 32.83
Adjusted EPS (Rs) 7.11 12.33 5.55 7.39 6.41

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 484.95 581.21 665.31 961.39 1117.13
Total Expenditure 348.47 433.74 489.25 676.52 807.22
Operating Profit 136.48 147.47 176.05 284.87 309.91
Other Income 15.63 20.52 29.32 12.31 16
Interest 2.88 3.37 10.01 11.26 24.15
Depreciation 13.97 15.44 30.85 43.78 55.88
Exceptional Items 0 0 -24.53 0 15.9
Profit Before Tax 135.26 149.19 139.99 242.13 261.78
Tax 39.51 47.73 27.94 59.48 69.54
Net Profit 95.76 101.46 112.05 182.65 192.24
Adjusted EPS (Rs.) 100.34 20.22 22.13 35.73 37.57

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 9.54 10.04 10.13 10.22 10.23
Total Reserves 354.49 405.37 502.26 654.59 813.89
Borrowings 0 0 0 0 158.68
Other N/C liabilities 78.43 141.21 166.3 113.78 117.68
Current liabilities 164.35 183.12 153.67 222.04 312.33
Total Liabilities 606.82 739.74 832.35 1000.63 1412.82
Assets
Net Block 157.02 162.9 215.78 307.09 314.06
Capital WIP 0 0 0 0 0
Intangible WIP 0 5.77 2.99 0 5.78
Investments 30.5 131.73 129.78 3.54 634.97
Loans & Advances 73.48 141.9 150.06 67.29 67.2
Other N/C Assets 27.15 11.08 11.67 1.64 11.78
Current Assets 318.67 286.36 322.08 621.06 379.03
Total Assets 606.82 739.74 832.35 1000.63 1412.82
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 135.26 149.19 139.99 242.13 261.78
Adjustment 4.78 3.8 49.41 71.33 49.42
Changes in Assets & Liabilities -18.92 -44.83 14.34 -22.16 -3.79
Tax Paid -46.64 -51.74 -47.61 -55.06 -70.26
Operating Cash Flow 74.48 56.43 156.13 236.23 237.15
Investing Cash Flow 18.86 -4.35 -51.13 59.42 -733.79
Financing Cash Flow -81.58 -63.97 -46.37 -31.27 173.14
Net Cash Flow 11.77 -11.89 58.63 264.38 -323.5

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Promoters 49.50 49.79 49.79 49.76 49.76
metz advisory llp 30.66 30.66 30.66 30.65 30.64
sushil kanubhai sh... 7.28 5.08 5.08 5.07 5.07
duru sushil shah 11.20 4.00 4.00 4.00 4.00
duru shah family t... - 7.20 7.20 7.19 7.19
sushil shah family... - 2.50 2.50 2.50 2.50
sushil kanubhai sh... - - - - -
duru sushil shah f... - - - - -
ameera sushil shah 0.36 0.36 0.36 0.36 0.36
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Investors 50.50 50.21 50.21 50.24 50.24
smallcap world fun... 5.65 2.60 - - -
uti flexi cap fund 3.94 4.61 5.27 5.37 6.77
aditya birla sun l... 4.13 4.72 3.82 3.60 2.72
bright star invest... 1.23 1.14 1.05 - -
icici prudential l... - 2.19 - - -
franklin india pri... - - - - -
j p morgan funds - - 1.33 1.66 2.15
grandeur peak inte... 1.46 1.68 1.96 2.15 1.26
bright star invest... - - - 1.07 -
indus india fund (... - - 1.52 1.53 -
j p morgan indian ... - - - - 1.27
icici prudential m... - - - - -
wasatch internatio... - - - - -
fundsmith emerging... - - - - -
matthews asia inno... - - - - -
llp 0.15 0.22 0.23 0.16 0.15

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Metropolis Healthcare informs about earnings call transcript18 Feb 2023, 11:01AM Metropolis Health. - Quaterly Results10 Feb 2023, 4:46PM Metropolis Health. - Quaterly Results10 Feb 2023, 4:46PM Metropolis Health. - Quaterly Results10 Feb 2023, 4:46PM Metropolis Healthcare informs about press release 9 Dec 2022, 12:48PM Metropolis Healthcare informs about disclosure 1 Dec 2022, 11:07AM Metropolis Healthcare informs about disclosure 1 Dec 2022, 11:06AM Metropolis Health. - Quaterly Results8 Nov 2022, 4:43PM Metropolis Health. - Quaterly Results8 Nov 2022, 4:43PM Metropolis Health. - Quaterly Results8 Nov 2022, 4:43PM Metropolis Healthcare informs about conference call1 Nov 2022, 11:41AM Metropolis Health. - Quaterly Results10 Aug 2022, 4:45PM Metropolis Health. - Quaterly Results10 Aug 2022, 4:45PM Metropolis Health. - Quaterly Results10 Aug 2022, 4:45PM Metropolis Healthcare informs about annual report27 Jul 2022, 12:55PM Metropolis Healthcare informs about certificate6 Jul 2022, 4:16PM Metropolis Healthcare informs about analyst meet intimation17 Jun 2022, 4:16PM Metropolis Health. - Quaterly Results24 May 2022, 6:34PM Metropolis Health. - Quaterly Results24 May 2022, 6:34PM Metropolis Healthcare informs about disclosure28 Feb 2022, 3:24PM Metropolis Healthcare informs about disclosure26 Feb 2022, 4:16PM Metropolis Health. - Quaterly Results11 Feb 2022, 4:19PM Metropolis Health. - Quaterly Results11 Feb 2022, 4:19PM Metropolis Health. - Quaterly Results11 Feb 2022, 4:19PM Metropolis Healthcare informs about conference call 7 Feb 2022, 9:50AM Metropolis Healthcare informs about disclosure2 Dec 2021, 9:55AM Metropolis Healthcare informs about disclosures 30 Nov 2021, 3:04PM Metropolis Healthcare informs about disclosures 29 Nov 2021, 3:53PM Metropolis Healthcare informs about disclosure23 Nov 2021, 9:47AM Metropolis Healthcare informs about disclosure18 Nov 2021, 9:40AM Metropolis Healthcare informs about disclosure17 Nov 2021, 4:13PM Metropolis Healthcare informs about conference call23 Oct 2021, 2:52PM Metropolis Healthcare informs about press release23 Oct 2021, 2:46PM Metropolis Healthcare completes 100% acquisition in Hitech, Centralab23 Oct 2021, 8:41AM Metropolis Healthcare’s board approves acquisition of Hitech Diagnostic Centre and its subsidiary16 Oct 2021, 11:01AM Metropolis Healthcare informs about analyst meet22 Sep 2021, 4:54PM Metropolis Healthcare informs about analyst meet30 Aug 2021, 12:50PM Metropolis Healthcare informs about proceedings of 21st AGM11 Aug 2021, 4:20PM Metropolis Healthcare gets nod to acquire balance 35% stake in Metropolis Histoxpert Digital Services6 Aug 2021, 4:38PM Metropolis Healthcare informs about board meeting31 Jul 2021, 1:24PM Metropolis Healthcare informs about investor meet24 Jun 2021, 11:29AM Metropolis Healthcare informs about investor meeting8 Jun 2021, 2:38PM Metropolis Healthcare informs about newspaper publication28 May 2021, 4:36PM Metropolis Healthcare informs about board meeting22 May 2021, 11:58AM Metropolis Healthcare achieves revenue growth of 40% in Q4FY218 Apr 2021, 3:53PM Metropolis Healthcare informs about disclosure5 Mar 2021, 4:57PM Metropolis Healthcare informs about transcripts of earning call2 Mar 2021, 11:47AM Metropolis Healthcare submits voting results for postal ballot20 Feb 2021, 3:37PM Metropolis Healthcare gets nod to acquire Hitech18 Jan 2021, 9:46AM Metropolis Healthcare wins ‘Diagnostic Company of the Year Award’ 10 Nov 2020, 9:45AM

Metropolis Health. Stock Price Analysis and Quick Research Report. Is Metropolis Health. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Metropolis Health. and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 237.1506 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Metropolis Health. has a Debt to Equity ratio of 0.3183 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Metropolis Health. , the EPS growth was 5.13535221239929 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Metropolis Health. has OPM of 27.7417609006503 % which is a good sign for profitability.
     
  • ROE: Metropolis Health. have a healthy ROE of 26.179860624307 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Metropolis Health.

X